Home/Filings/4/0001213900-25-073088
4//SEC Filing

Shoemaker Stephen H 4

Accession 0001213900-25-073088

CIK 0001690080other

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 4:15 PM ET

Size

6.8 KB

Accession

0001213900-25-073088

Insider Transaction Report

Form 4
Period: 2025-07-29
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2025-07-29+919,761919,761 total
    Exercise: $2.92Exp: 2035-07-29Common Stock (919,761 underlying)
Holdings
  • Common Stock

    132,439
Footnotes (2)
  • [F1]The options were granted under the 2025 Supplemental Option Plan of the Issuer. The options vested immediately, but were not exercisable until or unless the closing of the transactions contemplated by the July 29, 2025, Securities Purchase Agreement between the Issuer and the purchasers set forth therein occurred, which closing date was August 4, 2025. Separately, the options are not exercisable until stockholder approval of the 2025 Plan is received. If stockholder approval is not received prior to July 29, 2026, the options will be cancelled.
  • [F2]Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a director of the Issuer.

Issuer

180 Life Sciences Corp.

CIK 0001690080

Entity typeother

Related Parties

1
  • filerCIK 0002048098

Filing Metadata

Form type
4
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:15 PM ET
Size
6.8 KB